Catching up on recent FDA approvals. The FDA recently approved a new oral therapy, Sohonos (palovarotene) from Ipsen Biopharmaceuticals, for reduction in the volume of
Catching up on recent approvals…….. The FDA recently approved a new oral therapy, Akeega (niraparib and abiraterone acetate) from Janssen Pharmaceutical, the first-and-only dual action
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely
It’s ALIVE!!! Artificial Intelligence is here. The article below details how HCSC, which covers about 18 million members in Illinois, Montana, New Mexico, Oklahoma and Texas,
Catching up on a slew of FDA approvals in recent weeks….. whew! The FDA recently approved a new therapy, Veopoz (pozelimab-bbfg) from Regeneron, for the treatment
Catching up on recent approvals….. Earlier this week we sent a Report on the approval of Talvey from Janssen Pharmaceuticals indicated for he treatment of
Catching up on recent approvals….. The FDA recently approved a new subcutaneous therapy, Talvey (talquetamab-tgvs) from Janssen Pharmaceutical (a J&J company) for the treatment of
Now here’s a two-fer for ya. First, there’s the news that another specialty pharmacy has been christened. Second, we learn what a group of zebras
When I was a kid going to Yankee Stadium for a baseball outing the hawkers selling programs would say…. “Ya can’t tell the players without a
Earlier this year the Pharmaceutical Strategies Group published a nifty report on trends in pharmacy benefits management. And, lo and behold, PSG has now doubled down
